Results 71 to 80 of about 181,481 (200)
This multicentre retrospective study evaluated the 1-year outcomes and safety profile of faricimab in treatment-naïve patients with neovascular age-related macular degeneration (nAMD).
Ryo Mukai +21 more
doaj +1 more source
Background Intravitreal faricimab, a bispecific antibody targeting both angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), was recently introduced for the treatment of neovascular age-related macular degeneration (nAMD), diabetic ...
Gabriela Grimaldi +5 more
doaj +1 more source
Association Between Visual Acuity and Fluid Compartments with Treat-and-Extend Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis [PDF]
Varun Chaudhary +9 more
openalex +1 more source
Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients’ persistence [PDF]
Ingo Volkmann +4 more
openalex +1 more source
Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes. [PDF]
Trejo Corona S +8 more
europepmc +1 more source
Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (
Rakesh Popat +11 more
openalex +1 more source

